All In Biotech

Drug Trial Radar · NCT03140423

Mupirocin-Iodophor ICU Decolonization Swap Out Trial

Cluster-randomized Non-inferiority Trial Comparing Mupirocin vs Iodophor for Nasal Decolonization of ICU Patients to Assess Impact on S. Aureus Clinical Cultures and All-cause Bloodstream Infection During Routine Chlorhexidine Bathing

Last checked: Nov 19, 2026Latest source record: Mar 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 353,323 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

353,323

Actual

Start

May 1, 2017

Primary completion

Nov 6, 2023

Study completion Nov 6, 2023

Sponsor

Lead sponsor
Harvard Pilgrim Health CareAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Hospital Corporation of America; University of California, Irvine; University of Massachusetts, Amherst; Rush University; Centers for Disease Control and Prevention
First posted
May 4, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Swap Out Trial is a cluster randomized controlled trial of HCA hospitals, evaluating the non-inferiority of two decolonization regimens: Arm 1 Routine Care: ICU nasal decolonization with mupirocin twice daily for 5 days in the context of chlorhexidine for daily bathing; Arm 2 Intervention: ICU nasal decolonization with iodophor twice daily for 5 days in the context of chlorhexidine for daily bathing Note: that enrolled "subjects" represents 137 individual HCA Hospitals (representing \~235 ICUs) that have been randomized.

Conditions

  • Staphylococcus Aureus

Interventions

  • Arm 1. Routine Care (Mupirocin/CHG)Drug

    The intervention / decolonization regimen will consist of 5 days of topical intranasal mupirocin ointment (bilateral nares, twice daily) on ICU admission, in the context of continued daily baths with 2% chlorhexidine cloths.

  • Arm 2. Iodophor/CHG DecolonizationDrug

    The intervention / decolonization regimen will consist of 5 days of topical intranasal iodophor (10% povidone-iodine nasal swabs) (bilateral nares, twice daily) on ICU admission, in the context of continued daily baths with 2% chlorhexidine cloths.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With ICU-attributable Staphylococcus Aureus Clinical CulturesTime frame: 18-month intervention

Locations

137 sites in 1 country. Site status is shown where the registry gives one.

  • Riverside Community Hospital

    Riverside, California

  • Regional Medical Center of San Jose

    San Jose, California

  • Good Samaritan Hospital

    San Jose, California

  • Los Robles Regional Medical Center

    Thousand Oaks, California

  • West Hills Hospital & Medical Center

    West Hills, California

  • The Medical Center of Aurora

    Aurora, Colorado

  • Swedish Medical Center

    Denver, Colorado

  • Sky Ridge Medical Center

    Denver, Colorado

  • Presbyterian St. Luke's Medical Center

    Denver, Colorado

  • Rose Medical Center

    Denver, Colorado

  • North Suburban Medical Center - JV

    Thornton, Colorado

  • JFK Medical Center

    Atlantis, Florida

  • Aventura Hospital

    Aventura, Florida

  • Blake Medical Center

    Bradenton, Florida

  • Brandon Regional

    Brandon, Florida

  • Oak Hill Hospital

    Brooksville, Florida

  • Englewood Community Hospital

    Englewood, Florida

  • Fort Walton Medical Center

    Fort Walton Beach, Florida

  • Lawnwood Regional Medical Center

    Ft. Pierce, Florida

  • North Florida Regional Medical Center

    Gainesville, Florida

  • Regional Medical Center Bayonet Point

    Hudson, Florida

  • Memorial Hospital Jacksonville

    Jacksonville, Florida

  • Osceola Regional Medical Center

    Kissimmee, Florida

  • Poinciana Medical Center

    Kissimmee, Florida

  • Lake City Medical Center

    Lake City, Florida

  • Largo Medical Center

    Largo, Florida

  • Palms West Hospital

    Loxahatchee Groves, Florida

  • Northwest Medical Center

    Margate, Florida

  • Mercy Hospital

    Miami, Florida

  • Kendall Regional Medical Center

    Miami, Florida

  • Twin Cities Hospital

    Niceville, Florida

  • Ocala Regional Medical Center

    Ocala, Florida

  • West Marion Community Hospital

    Ocala, Florida

  • Raulerson Hospital

    Okeechobee, Florida

  • Orange Park Medical Center

    Orange Park, Florida

  • Gulf Coast Medical Center

    Panama City, Florida

  • West Florida Hospital

    Pensacola, Florida

  • Plantation General Hospital

    Plantation, Florida

  • Westside Regional Medical Center

    Plantation, Florida

  • Fawcett Memorial Hospital

    Port Charlotte, Florida

Showing 40 of 137 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.